Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
357 studies found for:    Open Studies | "heart disease"OR"stroke"OR"cardiovascular disease" | United States | Phase 1, 2, 3, 0 | Industry
Show Display Options
Rank Status Study
21 Recruiting Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke
Conditions: Acute Ischemic Stroke;   Thrombotic Disease
Interventions: Drug: DS-1040b;   Drug: placebo
22 Recruiting Safety and Efficacy of NA-1 in Subjects Undergoing Endovascular Thrombectomy for Stroke (ESCAPE-NA1)
Condition: Stroke, Acute
Interventions: Drug: NA-1, 2.6 mg/kg;   Drug: Placebo
23 Recruiting Safety and Efficacy of Intravenous Natalizumab in Acute Ischemic Stroke
Condition: Acute Ischemic Stroke
Interventions: Drug: natalizumab;   Drug: Placebo
24 Recruiting HT-3951 vs. Placebo in Stroke Rehabilitation
Condition: Ischemic Stroke
Interventions: Drug: HT-3951;   Drug: Placebo
25 Recruiting A Study to Evaluate the Efficacy and Safety of TF0023 Spray on Subjects With Ischemic Strokes
Condition: Ischemic Stroke
Intervention: Drug: TF0023
26 Recruiting A Study to Evaluate the Effect of the Transient Receptor Potential Vanilloid 4 (TRPV4) Channel Blocker, GSK2798745, on Pulmonary Gas Transfer and Respiration in Patients With Congestive Heart Failure
Condition: Heart Failure, Congestive
Interventions: Drug: GSK2798745;   Drug: Placebo
27 Recruiting Ubiquinol as a Metabolic Resuscitator in Post-Cardiac Arrest
Condition: Cardiac Arrest
Interventions: Drug: Ubiquinol;   Dietary Supplement: Ensure
28 Recruiting Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)
Conditions: Stroke;   Secondary Prevention
Interventions: Drug: optional ASA as comedication;   Drug: placebo to ASA;   Drug: placebo to optional ASA as comedication;   Drug: placebo to dabigatran etexilate;   Drug: ASA 100 mg;   Drug: dabigatran etexilate
29 Recruiting Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation
Conditions: Coronary Artery Bypass Grafting;   Postoperative Atrial Fibrilation;   Stroke;   Systemic Embolism;   Deep Venous Thrombosis
Interventions: Drug: Apixaban;   Drug: Warfarin
30 Recruiting A Study of the Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist (VKA) or Low Molecular Weight Heparin (LMWH) in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring Anticoagulation
Condition: Thrombosis
Interventions: Drug: Apixaban;   Drug: Vitamin K Antagonist (VKA);   Drug: Low Molecular Weight Heparin (LMWH)
31 Recruiting Implant for Augmentation of Cerebral Blood Flow Trial, Effectiveness and Safety in a 24 Hour Window
Condition: Ischemic Stroke
Interventions: Device: The Ischemic Stroke System;   Device: Sham control
32 Not yet recruiting Inhaled Nitric Oxide After Out-of-Hospital Cardiac Arrest
Condition: Heart Arrest, Out-Of-Hospital
Interventions: Drug: Nitric Oxide;   Drug: Nitrogen
33 Recruiting Fontan Udenafil Exercise Longitudinal Assessment Trial
Condition: Single Ventricle Heart Disease
Interventions: Drug: Udenafil;   Drug: Placebo
34 Recruiting A Extension Study of Udenafil in Adolescents
Condition: Functional Single Ventricle Heart Disease
Intervention: Drug: Udenafil
35 Recruiting CardiAMP™ Heart Failure Trial
Condition: Heart Failure
Interventions: Biological: Autologous cell therapy;   Device: CardiAMP cell therapy;   Other: Sham
36 Recruiting A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
Condition: Prostate Cancer
Interventions: Drug: Degarelix;   Drug: Leuprolide
37 Recruiting A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart Failure
Conditions: Heart Failure;   Coronary Artery Disease
Interventions: Drug: Rivaroxaban;   Drug: Placebo;   Other: Standard of care for heart failure and coronary artery disease
38 Recruiting Caisson Transcatheter Mitral Valve Replacement (TMVR) System Early Feasibility Study
Condition: Mitral Valve Regurgitation
Intervention: Device: Caisson TMVR System
39 Recruiting Inorganic Nitrite to Amplify the Benefits and Tolerability of Exercise Training in HFpEF (INABLE-Training)
Condition: Heart Failure
Interventions: Drug: Placebo Solution;   Drug: Sodium Nitrite Inhalation Solution;   Device: Accelerometer;   Other: Cardiac Exercise Training
40 Recruiting Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LCZ696 Followed by a 52-week Study of LCZ696 Compared With Enalapril in Pediatric Patients With Heart Failure
Condition: Pediatric Heart Failure
Interventions: Drug: LCZ696;   Drug: Enalapril;   Drug: Placebo of LCZ696;   Drug: Placebo of Enalapril

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.